Klaus Pantel

81.7k total citations · 25 hit papers
721 papers, 54.1k citations indexed

About

Klaus Pantel is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Klaus Pantel has authored 721 papers receiving a total of 54.1k indexed citations (citations by other indexed papers that have themselves been cited), including 483 papers in Oncology, 373 papers in Cancer Research and 222 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Klaus Pantel's work include Cancer Cells and Metastasis (371 papers), Cancer Genomics and Diagnostics (285 papers) and Prostate Cancer Treatment and Research (55 papers). Klaus Pantel is often cited by papers focused on Cancer Cells and Metastasis (371 papers), Cancer Genomics and Diagnostics (285 papers) and Prostate Cancer Treatment and Research (55 papers). Klaus Pantel collaborates with scholars based in Germany, United States and France. Klaus Pantel's co-authors include Catherine Alix‐Panabières, Heidi Schwarzenbach, Sabine Riethdorf, Ruud H. Brakenhoff, Volkmar Müller, Dave S.�B. Hoon, Harriet Wikman, Wolfgang Janni, Yibin Kang and Stephan Braun and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Klaus Pantel

695 papers receiving 53.3k citations

Hit Papers

Cell-free nucleic acids as biomarkers in cancer pa... 2000 2026 2008 2017 2011 2007 2014 2004 2014 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cell-free nucleic acids as biomarkers in cancer patients
    2011 2.2k citations Heidi Schwarzenbach, Klaus Pantel et al. profile →
  2. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System
    2007 1.1k citations Sabine Riethdorf, Volkmar Müller et al. Clinical Cancer Research profile →
  3. PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
    2014 1.1k citations Harriet Wikman, Klaus Pantel et al. profile →
  4. Dissecting the metastatic cascade
    2004 1.0k citations Klaus Pantel, Ruud H. Brakenhoff profile →
  5. Challenges in circulating tumour cell research
    2014 1.0k citations Catherine Alix‐Panabières, Klaus Pantel profile →
  6. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
    2016 1.0k citations Catherine Alix‐Panabières, Klaus Pantel Cancer Discovery profile →
  7. Detection, clinical relevance and specific biological properties of disseminating tumour cells
    2008 930 citations Klaus Pantel, Ruud H. Brakenhoff et al. profile →
  8. Circulating Tumor Cells: Liquid Biopsy of Cancer
    2012 899 citations Catherine Alix‐Panabières, Klaus Pantel profile →
  9. Clinical relevance of circulating cell-free microRNAs in cancer
    2014 862 citations Heidi Schwarzenbach, Klaus Pantel et al. profile →
  10. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
    2013 836 citations Andreas Schneeweiß, Sabine Riethdorf et al. profile →
  11. In vitro differentiation of endothelial cells from AC133-positive progenitor cells
    2000 795 citations Klaus Pantel, Gunter Schuch et al. profile →
  12. Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
    2000 726 citations Stephan Braun, Klaus Pantel et al. profile →
  13. Liquid biopsy and minimal residual disease — latest advances and implications for cure
    2019 721 citations Klaus Pantel, Catherine Alix‐Panabières profile →
  14. Tumor metastasis: moving new biological insights into the clinic
    2013 620 citations Klaus Pantel et al. profile →
  15. Circulating tumour cells in cancer patients: challenges and perspectives
    2010 610 citations Klaus Pantel, Catherine Alix‐Panabières profile →
  16. Cancer micrometastases
    2009 517 citations Klaus Pantel, Catherine Alix‐Panabières et al. profile →
  17. Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
    2014 472 citations Brigitte Rack, Julia Jückstöck et al. profile →
  18. Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
    2016 462 citations Sabine Riethdorf, Klaus Pantel et al. profile →
  19. Biology, detection, and clinical implications of circulating tumor cells
    2014 422 citations Simon A. Joosse, Tobias M. Gorges et al. profile →
  20. The biology of circulating tumor cells
    2015 410 citations Klaus Pantel, Michael R. Speicher profile →
  21. Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
    2019 405 citations Klaus Pantel et al. profile →
  22. VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors
    2011 397 citations Sabine Riethdorf, Klaus Pantel et al. profile →
  23. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
    2022 355 citations François‐Clément Bidard, Klaus Pantel et al. profile →
  24. Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
    2020 274 citations Harriet Wikman, Klaus Pantel et al. profile →
  25. Circulating tumour cells for early detection of clinically relevant cancer
    2023 205 citations Klaus Pantel et al. profile →

Peers

Klaus Pantel
Daniel A. Haber United States
Massimo Cristofanilli United States
Robert S. Kerbel Canada
Kornélia Polyák United States
David N. Louis United States
Isaiah J. Fidler United States
Daniel D. Von Hoff United States
Anirban Maitra United States
Max S. Wicha United States
José Baselga United States
Daniel A. Haber United States
Klaus Pantel
Citations per year, relative to Klaus Pantel Klaus Pantel (= 1×) peers Daniel A. Haber

Countries citing papers authored by Klaus Pantel

Since Specialization
Citations

This map shows the geographic impact of Klaus Pantel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Pantel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Pantel more than expected).

Fields of papers citing papers by Klaus Pantel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Pantel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Pantel. The network helps show where Klaus Pantel may publish in the future.

Co-authorship network of co-authors of Klaus Pantel

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Pantel. A scholar is included among the top collaborators of Klaus Pantel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Pantel. Klaus Pantel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ehlken, Hanno, Rüdiger Schmitz, Sabine Riethdorf, et al.. (2021). Possible tumour cell reimplantation during curative endoscopic therapy of superficial Barrett’s carcinoma. Gut. 71(2). 277–286. 1 indexed citations
3.
Wroblewski, Mark, Isabel Ben‐Batalla, Ines Miranda Santos, et al.. (2018). Blockade of Myeloid-Derived Suppressor Cell Expansion with All- Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy. Cancer Research. 78(12). 3220–3232. 97 indexed citations
4.
Croset, Martine, Francesco Pantano, Casina W.S. Kan, et al.. (2018). miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis–Associated Genes. Cancer Research. 78(18). 5259–5273. 150 indexed citations
5.
Alix‐Panabières, Catherine & Klaus Pantel. (2016). Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy. Cancer Discovery. 6(5). 479–491. 1020 indexed citations breakdown →
6.
Janni, Wolfgang, Brigitte Rack, Leon W.M.M. Terstappen, et al.. (2016). Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer. Clinical Cancer Research. 22(10). 2583–2593. 265 indexed citations
7.
Gorges, Tobias M., Simon A. Joosse, Sabine Riethdorf, et al.. (2015). Enumeration and Molecular Characterization of Tumor Cells in Lung Cancer Patients Using a Novel In Vivo Device for Capturing Circulating Tumor Cells. Clinical Cancer Research. 22(9). 2197–2206. 129 indexed citations
8.
Bartkowiak, Kai, Marcel Kwiatkowski, Friedrich Buck, et al.. (2015). Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients through Sustained Activation of the Unfolded Protein Response. Cancer Research. 75(24). 5367–5377. 65 indexed citations
9.
Nastały, Paulina, Christian Ruf, Natalia Bednarz‐Knoll, et al.. (2014). Circulating Tumor Cells in Patients with Testicular Germ Cell Tumors. Clinical Cancer Research. 20(14). 3830–3841. 41 indexed citations
10.
Gröbe, Alexander, Marco Blessmann, Henning Hanken, et al.. (2013). Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of Patients with Squamous Cell Carcinoma of the Oral Cavity. Clinical Cancer Research. 20(2). 425–433. 111 indexed citations
11.
Heitzer, Ellen, Martina Auer, Christin Gasch, et al.. (2013). Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing. Cancer Research. 73(10). 2965–2975. 403 indexed citations
12.
Madhavan, Dharanija, Manuela Zucknick, Markus Wallwiener, et al.. (2012). Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer. Clinical Cancer Research. 18(21). 5972–5982. 214 indexed citations
13.
Joosse, Simon A., Juliane Hannemann, Andreas Bauche, et al.. (2012). Changes in Keratin Expression during Metastatic Progression of Breast Cancer: Impact on the Detection of Circulating Tumor Cells. Clinical Cancer Research. 18(4). 993–1003. 126 indexed citations
14.
Barthel, Steven R., Matthew Opperman, Kempland C. Walley, et al.. (2012). Definition of Molecular Determinants of Prostate Cancer Cell Bone Extravasation. Cancer Research. 73(2). 942–952. 60 indexed citations
15.
Schwarzenbach, Heidi, et al.. (2012). Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression. Clinical Cancer Research. 18(20). 5719–5730. 50 indexed citations
16.
Janni, Wolfgang, Florian D. Vogl, Gro Wiedswang, et al.. (2011). Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis. Clinical Cancer Research. 17(9). 2967–2976. 192 indexed citations
17.
Bednarz‐Knoll, Natalia, Elke Eltze, Axel Semjonow, et al.. (2010). BRCA1 Loss Preexisting in Small Subpopulations of Prostate Cancer Is Associated with Advanced Disease and Metastatic Spread to Lymph Nodes and Peripheral Blood. Clinical Cancer Research. 16(13). 3340–3348. 53 indexed citations
18.
Ruosaari, Salla, Paul P. Eijk, Jussuf T. Kaifi, et al.. (2009). Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion. Clinical Cancer Research. 15(5). 1566–1574. 72 indexed citations
19.
Köllermann, Jens, Steffen Weikert, Martin Schostak, et al.. (2008). Prognostic Significance of Disseminated Tumor Cells in the Bone Marrow of Prostate Cancer Patients Treated With Neoadjuvant Hormone Treatment. Journal of Clinical Oncology. 26(30). 4928–4933. 62 indexed citations
20.
Loges, Sonja, Uta Reichelt, Michaël Bubenheim, et al.. (2007). Determination of Microvessel Density by Quantitative Real-time PCR in Esophageal Cancer: Correlation with Histologic Methods, Angiogenic Growth Factor Expression, and Lymph Node Metastasis. Clinical Cancer Research. 13(1). 76–80. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel A. Haber Breakdown of academic impact, for papers by Massimo Cristofanilli Breakdown of academic impact, for papers by Robert S. Kerbel Breakdown of academic impact, for papers by Kornélia Polyák Breakdown of academic impact, for papers by David N. Louis Breakdown of academic impact, for papers by Isaiah J. Fidler Breakdown of academic impact, for papers by Daniel D. Von Hoff Breakdown of academic impact, for papers by Anirban Maitra Breakdown of academic impact, for papers by Max S. Wicha Breakdown of academic impact, for papers by José Baselga
Rankless by CCL
2026